Accordingly, several studies demonstrate reduced DCA and LCA levels in active IBD patients, associated with gut dysbiosis (143), and consequently, NLRP3 can be permanently activated, exacerbating the inflammatory response. This evidence concerns the gene NLRP3 and inflammatory bowel disease.